TWD 15.9
(-9.92%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 3.82 Billion TWD | -13.29% |
2022 | 4.4 Billion TWD | -2.86% |
2021 | 4.53 Billion TWD | -6.16% |
2020 | 4.83 Billion TWD | 19.92% |
2019 | 4.03 Billion TWD | 14.28% |
2018 | 3.52 Billion TWD | -10.59% |
2017 | 3.94 Billion TWD | 14.87% |
2016 | 3.43 Billion TWD | 5.9% |
2015 | 3.24 Billion TWD | 3.6% |
2014 | 3.13 Billion TWD | 13.32% |
2013 | 2.76 Billion TWD | 16.24% |
2012 | 2.37 Billion TWD | 1.91% |
2011 | 2.33 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 3.88 Billion TWD | 1.7% |
2024 Q2 | 3.9 Billion TWD | 0.38% |
2023 Q3 | 3.73 Billion TWD | -1.15% |
2023 Q1 | 4.3 Billion TWD | -2.29% |
2023 Q2 | 3.77 Billion TWD | -12.29% |
2023 FY | 3.82 Billion TWD | -13.29% |
2023 Q4 | 3.82 Billion TWD | 2.35% |
2022 Q2 | 5.04 Billion TWD | 9.99% |
2022 Q3 | 4.41 Billion TWD | -12.52% |
2022 Q4 | 4.4 Billion TWD | -0.1% |
2022 Q1 | 4.58 Billion TWD | 1.07% |
2022 FY | 4.4 Billion TWD | -2.86% |
2021 Q3 | 4.66 Billion TWD | -2.67% |
2021 Q1 | 4.81 Billion TWD | -0.5% |
2021 Q2 | 4.79 Billion TWD | -0.31% |
2021 FY | 4.53 Billion TWD | -6.16% |
2021 Q4 | 4.53 Billion TWD | -2.8% |
2020 Q1 | 4.28 Billion TWD | 6.26% |
2020 Q2 | 4.95 Billion TWD | 15.65% |
2020 Q3 | 4.72 Billion TWD | -4.64% |
2020 FY | 4.83 Billion TWD | 19.92% |
2020 Q4 | 4.83 Billion TWD | 2.33% |
2019 Q2 | 3.91 Billion TWD | 1.74% |
2019 Q4 | 4.03 Billion TWD | -0.72% |
2019 FY | 4.03 Billion TWD | 14.28% |
2019 Q1 | 3.85 Billion TWD | 9.15% |
2019 Q3 | 4.06 Billion TWD | 3.66% |
2018 Q1 | 3.48 Billion TWD | -11.81% |
2018 FY | 3.52 Billion TWD | -10.59% |
2018 Q4 | 3.52 Billion TWD | -2.92% |
2018 Q3 | 3.63 Billion TWD | 0.15% |
2018 Q2 | 3.63 Billion TWD | 4.28% |
2017 Q3 | 3.65 Billion TWD | -10.91% |
2017 FY | 3.94 Billion TWD | 14.87% |
2017 Q4 | 3.94 Billion TWD | 8.07% |
2017 Q1 | 3.42 Billion TWD | -0.31% |
2017 Q2 | 4.09 Billion TWD | 19.67% |
2016 Q4 | 3.43 Billion TWD | 0.73% |
2016 Q3 | 3.41 Billion TWD | 2.39% |
2016 Q2 | 3.33 Billion TWD | 7.26% |
2016 Q1 | 3.1 Billion TWD | -4.27% |
2016 FY | 3.43 Billion TWD | 5.9% |
2015 Q3 | 3.48 Billion TWD | 11.75% |
2015 Q4 | 3.24 Billion TWD | -6.87% |
2015 Q2 | 3.11 Billion TWD | 1.79% |
2015 FY | 3.24 Billion TWD | 3.6% |
2015 Q1 | 3.06 Billion TWD | -2.2% |
2014 Q3 | 3.18 Billion TWD | 2.48% |
2014 Q1 | - TWD | -100.0% |
2014 Q2 | 3.11 Billion TWD | 0.0% |
2014 FY | 3.13 Billion TWD | 13.32% |
2014 Q4 | 3.13 Billion TWD | -1.77% |
2013 Q4 | 2.76 Billion TWD | 0.0% |
2013 FY | 2.76 Billion TWD | 16.24% |
2013 Q1 | 2.8 Billion TWD | 18.05% |
2013 Q2 | 2.8 Billion TWD | 0.0% |
2012 Q2 | 2.28 Billion TWD | 0.0% |
2012 FY | 2.37 Billion TWD | 1.91% |
2012 Q4 | 2.37 Billion TWD | 0.03% |
2012 Q3 | 2.37 Billion TWD | 4.03% |
2011 Q4 | 2.33 Billion TWD | 0.0% |
2011 FY | 2.33 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -31.776% |
Level Biotechnology Inc. | 822.67 Million TWD | -364.665% |
Sagittarius Life Science Corp | 664.72 Million TWD | -475.077% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -596.617% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 1.83% |
GlycoNex Incorporation | 1.55 Billion TWD | -146.177% |
VBI | 452.1 Million TWD | -745.533% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | -225.018% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -410.662% |
Visgeneer Inc. | 397.17 Million TWD | -862.463% |
Mycenax Biotech Inc. | 3.77 Billion TWD | -1.386% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -77.055% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -332.872% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 37.258% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -5096.812% |
Enimmune corporation | 604.82 Million TWD | -532.027% |
TaiRx, Inc. | 833.74 Million TWD | -358.493% |
CHO Pharma, Inc. | 3.08 Billion TWD | -23.87% |
EirGenix Inc. | 11.16 Billion TWD | 65.755% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -566.971% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | -123.24% |
Lin BioScience, Inc. | 3.59 Billion TWD | -6.282% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -263.897% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -1169.855% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -1344.387% |
Lukas Biomedical Inc. | 441.19 Million TWD | -766.444% |
RBC Bioscience Corporation | 753.79 Million TWD | -407.127% |
BiOptic Inc. | 613.77 Million TWD | -522.815% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | -114.917% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -229.622% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -492.801% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | -23.064% |
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2885.366% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -910.321% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -237.143% |
Neith Corporation | 192.15 Million TWD | -1889.389% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -2484.038% |
NaviFUS Corp. | 490.53 Million TWD | -679.286% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -211.872% |
Sinew Pharma Inc. | 1.36 Billion TWD | -180.383% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -622.423% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -229.147% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -130.799% |
AP Biosciences Inc | 890.75 Million TWD | -329.149% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 55.171% |
3D Global Biotech Inc. | 324.14 Million TWD | -1079.298% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | -186.634% |
Intech Biopharm Corporation | 2.71 Billion TWD | -41.002% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 75.119% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -831.772% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -863.251% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -84.143% |
TCI GENE Inc. | 1.16 Billion TWD | -227.862% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -1197.664% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | -180.392% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -305.907% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -447.307% |
PharmaEngine, Inc. | 3.95 Billion TWD | 3.319% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -210.827% |
OBI Pharma, Inc. | 5.6 Billion TWD | 31.785% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -259.947% |
Acepodia, Inc. | 6.81 Billion TWD | 43.937% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 0.1% |